Susanna V. Ulahannan MD

PubMed

• Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide.
  Vishnu Nagalapuram, Niveditha Popuri, Ryan D Nipp, Susanna V Ulahannan, Kelsey S Lau-Min
  JCO Oncology Practice. 2025-03-03
• 3 citations
  Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
  Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, Salvatore Battaglia, Marco Enea
  Hepatology. 2025-03-01
• CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid t...
  J Randolph Hecht, Jean-Marie Michot, David Bajor, Amita Patnaik, Ki Y Chung
  BJC Reports. 2025-02-27

Journal Articles

• Hepatocellular carcinoma and immune therapy, from a clinical perspective; where are we?  
  Ulahannan SV, Duffy AG, Hepatic Oncology, 8/19/2016
• Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750 - an antisense oligonucleotide against eIF4E - in combinati...  
  Duffy A, Makarova-Rusher OV, Ulahannan SV et al, Internal Journal of Cancer, 1/19/2016
• Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades  
  Ulahannan SV, Rahma OE, Duffy AG, et al, Hepatic Oncology, 1/1/2015
• A phase II study of TRC 105 in patients with hepatocellular carcinoma who have progressed on Sorafenib  
  Duffy A, Ulahannan SV, Cao L et al, United European Gastroenterology Journal, 1/1/2015
• Antiangiogenic Agents in Combination with Chemotherapy in Patients with Non-Small-Cell Lung Cancer  
  Ulahannan SV, Brahmer JR, Cancer Investigation, 1/1/2011
• Join now to see all

Books/Book Chapters

• Cancer Therapeutic Targets 
  Chapter: VEGF 
  Ulahannan SVEditors: Howard L. Kaufman and John L. Marshall.Springer
• Hematology-Oncology Therapy 
  Chapter: Gallbladder Cancer and Cholangiocarcinoma 
  Greten T, Ulahannan SVEditors: Tito Fojo.

Abstracts/Posters

• Epidemiology and Survival in Patients with Extragastric Signet Ring Carcinoma
  C Kim, SV Ulahannan, J Strauss et al, American association for Cancer Research (AACR), New Orleans, LA, 1/1/2016
• Pretreatment CEA levels predict survival in patients with rectal adenocarcinoma
  OV Makarova-Rusher, J Strauss, SV Ulahannan et al, American association for Cancer Research (AACR), New Orleans, LA, 1/1/2016
• Tremelimumab: A monoclonal antibody against CTLA-4-In combination with subtotal ablation (trans catheter arterial chemoembolization (TACE), radiofrequency ablation (RF...
  Austin G. Duffy, Oxana V. Makarova-Rusher, Susanna Ulahannan et al, J Clin Oncol; ASCO Annual Meeting, Chicago, IL, 1/1/2016
• Racial/ethnic disparitiesin hepatocellular carcinoma treatment and survival: Are we making progress?
  OV Makarova-Rusher, KA Erokhina, AG Duffy, SV Ulahannan, TF Greten, J Clin Oncol, 1/1/2015
• Risk factors for hepatocellular carcinoma (HCC) by race/ethnicity in the United States
  OV Makarova-Rusher, SF Aletekrus, TF McNeel, BI Graubard, AG Duffy, SV Ulahannan et al, AACR annual meeting, 1/1/2015
• Phase I/II study of ISIS 183750 in combination with irinotecan for advanced solid tumors or colorectal cancer. Final results
  OV Makarova-Rusher, AG Duffy SV Ulahannan, et al, J Clin Oncol; Gastrointestinal Cancers Symposium, San Francisco, CA, 1/1/2015
• A phase I/II study of TRC 105 in combination with sorafenib in hepatocellular carcinoma (HCC)
  AG Duffy, C Ma, SV Ulahannan et al, J Clin Oncol; ASCO Annual Meeting, Chicago, IL, 1/1/2015
• Curative treatments and survival benefits in elderly patients with hepatocellular carcinoma: A SEER population-based analysis
  OV Makarova-Rusher, SV Ulahannan, AG Duffy et al, J Clin Oncol; Gastrointestinal Cancers Symposium, San Francisco, CA, 1/1/2015
• Pancreatic squamous cell carcinoma: Epidemiology, clinicopathologic characteristics, and outcomes
  OV Makarova-Rusher, SV Ulahannan, AG Duffy et al, J Clin Oncol; Gastrointestinal Cancers Symposium, San Francisco, CA, 1/1/2015
• Disconnect between earlier presentation patterns and application of curative treatments in HCC
  SV Ulahannan, A. Duffy, J. Kish, K. McGlynn, O. Rahma, T. Greten, S. Altekruse, J Clin Oncol; Gastrointestinal Cancers Symposium, San Francisco, CA, 1/1/2014
• Systemic chemotherapy for the treatment of advanced biliary tract carcinoma (BTC)
  SV Ulahannan, OE Rahma, Liewehr J et al, J Clin Oncol, 1/1/2014
• Changing patterns of hepatocellular carcinoma incidence, tumor size and treatment in SEER registries, 2000-2010
  SV Ulahannan, A. Duffy, TS McNeel, KA McGlynn, TF Greten, S Altekruse, 14th Annual CCR Fellows and Young Investigators Colloquium, 1/1/2014
• TRC105 for the treatment of hepatocellular carcinoma: Preclinical data and preliminary results from two clinical trials evaluating monotherapy and combination with sor...
  A Duffy, C Ma, SV Ulahannan, S Fioravanti, A Venkatesan, I Turkbey, PL Choyke, JB.Trepel, L Cao, K Compton, WD Figg, TF Greten, J Clin Oncol; Gastrointestinal Cancers Symposium, San Francisco, CA, 1/1/2014
• A pilot study of tremelimumab, a monoclonal antibody against CTLA-4, in combination with either TACE or RFA in patients with HCC
  Duffy A, Ulahannan SV, Fioravanti S, J Clin Oncol, 1/1/2014
• Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 in combination with ablative therapy in ...
  AG Duffy, SP Kerkar, DE Kleiner, SV Ulahannan et al, Journal for ImmunoTherapy of Cancer; Annual Meeting of Society for Immunotherapy of Cancer, National Harbor, MD, 1/1/2014
• Trc105 For The Treatment Of Hepatocellular Carcinoma: Preclinical Data And Preliminary Results From Two Clinical Trials Evaluating Monotherapy And Combination With Sor...
  Duffy A, Ma C, Ulahannan SV, Rahma O, Fioravanti S, Venkatesan A, Turkbey B, Choyke P, Trepel J, Figg W, Greten T, International Liver Cancer Association Annual meeting, Washington, DC, 1/1/2013
• A phase II study of TRC105 in patients with hepatocellular carcinoma C (HCC) who have progressed on sorafenib
  A Duffy, OE Rahma, SV Ulahannan et al, J Clin Oncol, 1/1/2013
• Join now to see all